FDA Drug Recalls

Recalls / Class II

Class IID-973-2013

Product

LIDOCAINE MDV 1% INJECTABLE, LIDOCAINE MDV 20 MG/ML INJECTABLE and Lidocaine PF 20 MG/ML INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI

Affected lot / code info
02262013@10, 03062013@29, 06252013@17, 07092013@18, 05092013@14

Why it was recalled

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Recalling firm

Firm
Beacon Hill Medical Pharmacy, P.C.
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
18161 W 13 Mile Rd, Suite A1, Southfield, Michigan 48076-1113

Distribution

Quantity
N/A
Distribution pattern
USA nationwide

Timeline

Recall initiated
2013-07-26
FDA classified
2013-09-10
Posted by FDA
2013-09-18
Terminated
2014-07-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-973-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls